Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Research identifies gene variants that play key role in how ovarian cancer patients process chemotherapy

Research identifies gene variants that play key role in how ovarian cancer patients process chemotherapy

Fathers maybe passing on ovarian cancer genes to their daughters

Fathers maybe passing on ovarian cancer genes to their daughters

Using Smartphones for Cancer Diagnosis and Management

Using Smartphones for Cancer Diagnosis and Management

USPSTF recommends against ovarian cancer screening in women without symptoms

USPSTF recommends against ovarian cancer screening in women without symptoms

Patients with Huntington's have lesser cancer than general population

Patients with Huntington's have lesser cancer than general population

Scientists develop new array to identify biomarkers for wide range of diseases

Scientists develop new array to identify biomarkers for wide range of diseases

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Researchers identify promising new drug target for Ewing sarcoma

Researchers identify promising new drug target for Ewing sarcoma

New test predicts which BRCA2 gene mutations lead to breast, ovarian cancers

New test predicts which BRCA2 gene mutations lead to breast, ovarian cancers

Researchers develop single blood test that screens for 8 cancer types

Researchers develop single blood test that screens for 8 cancer types

Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations

Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations

Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations

Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations

FDA grants approval for first drug to treat inherited breast cancer

FDA grants approval for first drug to treat inherited breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

BRCA gene mutation does not raise the risk of death

BRCA gene mutation does not raise the risk of death

Researchers describe key cellular receptor involved in ovarian cancer metastasis

Researchers describe key cellular receptor involved in ovarian cancer metastasis

Study uncovers genomic targets in refractory neuroblastoma

Study uncovers genomic targets in refractory neuroblastoma

Study finds combination therapy as effective strategy to treat ovarian cancers

Study finds combination therapy as effective strategy to treat ovarian cancers